Detalhe da pesquisa
1.
Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment.
Cell
; 176(4): 757-774.e23, 2019 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712866
2.
A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma.
Br J Cancer
; 125(5): 699-713, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172930
3.
Role of miR-195 in aortic aneurysmal disease.
Circ Res
; 115(10): 857-66, 2014 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25201911
4.
LAP1 supports nuclear adaptability during constrained melanoma cell migration and invasion.
Nat Cell Biol
; 25(1): 108-119, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36624187
5.
WNT11-FZD7-DAAM1 signalling supports tumour initiating abilities and melanoma amoeboid invasion.
Nat Commun
; 11(1): 5315, 2020 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33082334
6.
Upregulated heme biosynthesis, an exploitable vulnerability in MYCN-driven leukemogenesis.
JCI Insight
; 2(15)2017 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28768907
7.
Prader-Willi Critical Region, a Non-Translated, Imprinted Central Regulator of Bone Mass: Possible Role in Skeletal Abnormalities in Prader-Willi Syndrome.
PLoS One
; 11(1): e0148155, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26824232